Long-term administration of enteric-coated mycophenolate sodium (EC-MPS; myfortic®) is safe in kidney transplant patients

M. Salvadori, H. Holzer, G. Civati, H. Sollinger, B. Lien, S. Tomlanovich, E. Bertoni, Y. Seifu, A. C. Marrast, Angelo M DeMattos, William Bennett, Mysore Kumar, Raymond Margreiter, Ferdinand Muehlbacher, Karoly Kalmar-Nagy, Martin Wilkie, Kenneth Brayman, Clyde Barker, Ferenc Perner, Miguel GentilMiguel Gonzalez Molina, David Russell, Heide Sperschneider, A. Barama, Serder Yilmaz, Pal Szenohradszky, L. Asztalos, Dietmar Abendroth, Domingo del Castillo, Bernhard Krämer, Wolfgang Arns, Viken Douzdijan, Igor Bajjoka, Yodit Seifu, Anne Claire Marrast

Research output: Contribution to journalArticlepeer-review

25 Scopus citations

Fingerprint

Dive into the research topics of 'Long-term administration of enteric-coated mycophenolate sodium (EC-MPS; myfortic®) is safe in kidney transplant patients'. Together they form a unique fingerprint.

Medicine & Life Sciences